Abstract:BACKGROUND:Gastric cancer (GC) represents a significant health burden with dire prognostic implications upon metastasis and recurrence. Pterostilbene (PTE) has been proven to have a strong ability to inhibit proliferation and metastasis in other cancers, while whether PTE exhibits anti-GC activity and its potential mechanism remain unclear.PURPOSE:To explore the efficacy and potential mechanism of PTE in treating GC.METHODS:We employed a comprehensive set of assays, including CCK-8, EdU staining, colony formation, flow cytometry, cell migration, and invasion assays, to detect the effect of PTE on the biological function of GC cells in vitro. The xenograft tumor model was established to evaluate the in vivo anti-GC activity of PTE. Network pharmacology was employed to predict PTE's potential targets and pathways within GC. Subsequently, Western blotting, immunofluorescence, and immunohistochemistry were utilized to analyze protein levels related to the cell cycle, EMT, and the JAK2/STAT3 pathway.RESULTS:Our study demonstrated strong inhibitory effects of PTE on GC cells both in vitro and in vivo. In vitro, PTE significantly induced cell cycle arrest at G0/G1 and S phases and suppressed proliferation, migration, and invasion of GC cells. In vivo, PTE led to a dose-dependent reduction in tumor volume and weight. Importantly, PTE exhibited notable safety, leaving mouse weight, liver function, and kidney function unaffected. The involvement of the JAK2/STAT3 pathway in PTE's anti-GC effect was predicted utilizing network pharmacology. PTE suppressed JAK2 kinase activity by binding to the JH1 kinase structural domain and inhibited the downstream STAT3 signaling pathway. Western blotting confirmed PTE's inhibition of the JAK2/STAT3 pathway and EMT-associated protein levels. The anti-GC effect was partially reversed upon STAT3 activation, validating the pivotal role of the JAK2/STAT3 signaling pathway in PTE's activity.CONCLUSION:Our investigation validates the potent inhibitory effects of PTE on the proliferation and metastasis of GC cells. Importantly, we present novel evidence implicating the JAK2/STAT3 pathway as the key mechanism through which PTE exerts its anti-GC activity. These findings not only establish the basis for considering PTE as a promising lead compound for GC therapeutics but also contribute significantly to our comprehension of the intricate molecular mechanisms underlying its exceptional anti-cancer properties.

Pterostilbene Induces Cell Apoptosis and Cell Cycle Arrest in T-Cell Leukemia/Lymphoma by Suppressing the ERK1/2 Pathway.

Pterostilbene induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma cells

Pterostilbene Simultaneously Induces Apoptosis, Cell Cycle Arrest and Cyto-Protective Autophagy in Breast Cancer Cells.

Pterostilbene Inhibits Human Multiple Myeloma Cells Via ERK1/2 and JNK Pathway in Vitro and in Vivo.

Triptolide Down-regulates Bcr-abl Expression and Induces Apoptosis in Chronic Myelogenous Leukemia Cells

Triptolide Inhibits the Proliferation of Cells from Lymphocytic Leukemic Cell Lines in Association with Downregulation of NF-κB Activity and Mir-16-1*.

Targeting the PI3K/Akt/mTOR Signaling Pathway by Pterostilbene Attenuates Mantle Cell Lymphoma Progression

Long Non-coding RNAs Contribute to the Inhibition of Proliferation and EMT by Pterostilbene in Human Breast Cancer

Pterostilbene modulates the suppression of multidrug resistance protein 1 and triggers autophagic and apoptotic mechanisms in cisplatin-resistant human oral cancer CAR cells via AKT signaling

[Effect of Pterostilbene Regulating Nuclear Factor E2-Related Factor 2 on Apoptosis of Colon Cancer Cells in Vitro]

Pterostilbene Exerts Antitumor Activity Against Human Osteosarcoma Cells by Inhibiting the JAK2/STAT3 Signaling Pathway.

Linalool Preferentially Induces Robust Apoptosis of a Variety of Leukemia Cells Via Upregulating P53 and Cyclin-Dependent Kinase Inhibitors

Pterostilbene induces pyroptosis of breast cancer cells, inhibits the growth and invasion of transplanted tumor and reshapes its tumor microenvironment

Liriopesides B Induces Apoptosis and Cell Cycle Arrest in Human Non‑small Cell Lung Cancer Cells.

Pterostilbene, an Active Constituent of Blueberries, Suppresses Proliferation Potential of Human Cholangiocarcinoma Via Enhancing the Autophagic Flux

Stilbene B10 Induces Apoptosis and Tumor Suppression in Lymphoid Raji Cells by BTK-mediated Regulation of the KRAS/HDAC1/EP300/PEBP1 Axis

Effects of pterostilbene on the proliferation and apoptosis of human lung cancer A549 cell line

Anti-inflammatory Action of Pterostilbene Is Mediated through the p38 Mitogen-Activated Protein Kinase Pathway in Colon Cancer Cells

Tumoricidal Activities of Pterostilbene Depend Upon Destabilizing the MTA1-NuRD Complex and Enhancing P53 Acetylation in Hepatocellular Carcinoma

Pterostilbene Suppresses Gastric Cancer Proliferation and Metastasis by Inhibiting Oncogenic JAK2/STAT3 Signaling: in Vitro and in Vivo Therapeutic Intervention

Pterostilbene Acts Through Metastasis-Associated Protein 1 To Inhibit Tumor Growth, Progression And Metastasis In Prostate Cancer